FDA approves Itvisma for patients 2 years and older with SMA, making it the first FDA-approved gene replacement therapy for this population. FDA approved Itvisma as the first gene replacement therapy ...
FDA grants Breakthrough Device Designation to GeneDx genome and exome tests supporting diagnosis of life-threatening genetic disorders. The FDA has granted Breakthrough Device Designation to GeneDx’s ...
Ruth Lynfield, MD, discusses an approach clinicians can take in counseling parents who may have concerns about vaccines.
Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies. The prospective, randomized, ...
Ellen Fremion, MD, outlines strategies to support smooth transitions from pediatric to adult care, stressing early planning and strong collaboration. Transition planning should begin early—ideally by ...
"The FDA is taking action to make parents and doctors aware of a considerable body of evidence about potential risks associated with acetaminophen. Even with this body of evidence, the choice still ...
Specifically, the ACIP voted 5-2 to recommend clesrovimab (Enflonsia; Merck), which was approved by the FDA on June 9, 2025, for infants aged 8 months and younger who are not protected by a maternal ...
With the new drug application accepted with priority review, the FDA has assigned a date of November 30, 2025, to complete its review for potential approval. On June 2, 2025, the FDA accepted a new ...
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest print issue of Contemporary Pediatrics I was excited to hear the announcement on March 5 th 2025, that the ...
The World Bank Group reports that as this global health emergency escalates, devastating impacts on health and well-being will also accelerate.
A CDC report shows only 23% of U.S. teens get enough sleep, with disparities highlighting the need for targeted health interventions. The findings regarding sleep behaviors highlight a trend of ...
Adolescent borderline personality disorder linked to high risk of ADHD, schizophrenia in later years
New international findings show BPD diagnosis in teenaged years may be a critical indicator of subsequent mental disorder into young adulthood. Approximately half of a pool of adolescent patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback